Avenue Therapeutics Inc. Stock
Price
Target price
-
-
-
-
-
?0.70
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Avenue Therapeutics Inc. Stock
The community is currently still undecided about Avenue Therapeutics Inc. with 2 Buy predictions and 0 Sell predictions.
For the coming years our community has positive and negative things to say abot the Avenue Therapeutics Inc. stock. Criterium "Company culture" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Avenue Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Avenue Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Avenue Therapeutics Inc. | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | 3.290% | 5.812% | 16.594% | -25.833% | -7.612% | -79.045% | -96.492% |
| Avid Bioservices Inc | -1.180% | 11.333% | 40.336% | -38.148% | 36.885% | -48.457% | 158.714% |
| Gritstone Oncology Inc | -0.070% | -5.430% | -0.290% | -62.156% | -62.971% | -90.796% | - |
Comments
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $0.75 price target on the stock.
Show more
Ratings data for ATXI provided by MarketBeat
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Aegis. They set a "buy" rating and a $32.00 price target on the stock.
Show more
Ratings data for ATXI provided by MarketBeat
